Delisting risk
InMed Pharmaceuticals (INM)
Develops cannabinoid-receptor small molecules for neurological, eye, and dermatology diseases.
$1.40
Pre-market+0.03 (+2.56%)
At close$1.37(+3.41%)
Something off on this page? Send us feedback.
Next report
Sep 23, 2026
estimated · in 20 days
EPS estimate
−$94.44
Revenue estimate
—
Fiscal quarter
Q4 FY26
EPSReportedEstimate
Nov '24Feb '25May '25Sep '25Nov '25Feb '26May '26Sep '26
Reported−$54.20−$3.64−$1.94−$3.80−$0.44−$0.51−$0.69Pending
Estimate——————−$94.44−$94.44
Surprise——————+99.3%—
RevenueReportedEstimate
Nov '24Feb '25May '25Sep '25Nov '25Feb '26May '26Sep '26
Reported$936.2K$772.5M$1.8M$1.8M$1.1M$1.1M$1.3MPending
Estimate——————$659.8M—
Surprise——————−99.8%—
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Sep 2026 | −$94.44 | — | — |
| May 2026 | −$94.44 | −$0.69 | +99.3% |
| Feb 2026 | — | −$0.51 | — |
| Nov 2025 | — | −$0.44 | — |
| Sep 2025 | — | −$3.80 | — |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Sep 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Sep 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Sep 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Sep 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Sep 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Sep 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Oct 2017 | |||
| Apr 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Oct 2016 | |||
| Mar 2016 | |||
| Dec 2015 | |||
| Sep 2015 | |||
| Jun 2015 | |||
| Mar 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | −$94.44 | — | — | — | — | — | — |
| May 6, 2026 | −$94.44 | −$0.69 | +99.3% | $659.8M | $1.3M | −99.8% | −4.1% |
| Feb 11, 2026 | — | −$0.51 | — | — | $1.1M | — | −10.1% |
| Nov 6, 2025 | — | −$0.44 | — | — | $1.1M | — | −6.4% |
| Sep 23, 2025 | — | −$3.80 | — | — | $1.8M | — | +1.9% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| May 12, 2025 | |||||||
| Feb 12, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Sep 27, 2024 | |||||||
| May 14, 2024 | |||||||
| Feb 13, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Sep 29, 2023 | |||||||
| May 15, 2023 | |||||||
| Feb 17, 2023 | |||||||
| Nov 11, 2022 | |||||||
| Sep 23, 2022 | |||||||
| May 13, 2022 | |||||||
| Feb 14, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Sep 24, 2021 | |||||||
| May 13, 2021 | |||||||
| Feb 11, 2021 | |||||||
| Dec 17, 2020 | |||||||
| Sep 8, 2020 | |||||||
| May 14, 2020 | |||||||
| Feb 14, 2020 | |||||||
| Nov 8, 2019 | |||||||
| Sep 19, 2019 | |||||||
| May 15, 2019 | |||||||
| Feb 12, 2019 | |||||||
| Nov 12, 2018 | |||||||
| Sep 13, 2018 | |||||||
| May 11, 2018 | |||||||
| Feb 22, 2018 | |||||||
| Nov 20, 2017 | |||||||
| Oct 12, 2017 | |||||||
| Apr 1, 2017 | |||||||
| Feb 27, 2017 | |||||||
| Nov 29, 2016 | |||||||
| Oct 13, 2016 | |||||||
| Mar 31, 2016 | |||||||
| Dec 31, 2015 | |||||||
| Sep 30, 2015 | |||||||
| Jun 30, 2015 | |||||||
| Mar 31, 2015 | |||||||